Zeldin Robert K — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Zeldin Robert K has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Profile

Robert K Zeldin is a biotech executive who serves as Chief Medical Officer of MeiraGTx Holdings plc (MGTX). In this role, he oversees medical strategy and clinical development for the company's gene therapy programs, including AAV-CNGB3, AAV-CNGA3, and AAV-RPGR, as MeiraGTx advances its ocular, salivary gland, and central nervous system indications.

Board memberships

• MeiraGTx Holdings plc

Awards & honors

• Oversees medical strategy and clinical development for MeiraGTx's gene therapy pipeline.
• Led medical leadership for programs including AAV-CNGB3, AAV-CNGA3, and AAV-RPGR.
• Collaborates with clinical trial partners and investigators to advance ocular/CNS gene therapies.

Recent Transactions

Companies — Last 90 Days

• MeiraGTx Holdings plc (MGTX) — 2 filings, last 2026-06-30

Frequently Asked Questions

Who is Zeldin Robert K?

Robert K Zeldin is a biotech executive who serves as Chief Medical Officer of MeiraGTx Holdings plc (MGTX). In this role, he oversees medical strategy and clinical development for the company's gene therapy programs, including AAV-CNGB3, AAV-CNGA3, and AAV-RPGR, as MeiraGTx advances its ocular, salivary gland, and central nervous system indications.…

How many SEC Form 4 filings has Zeldin Robert K submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Zeldin Robert K's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week